(BCI) abrdn Bloomberg All - Overview
Etf: Energy, Metals, Agriculture, Livestock
Dividends
| Dividend Yield | 16.23% |
| Yield on Cost 5y | 24.85% |
| Yield CAGR 5y | -7.86% |
| Payout Consistency | 70.3% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 25.2% |
| Relative Tail Risk | 1.58% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.86 |
| Alpha | 10.56 |
| Character TTM | |
|---|---|
| Beta | 0.264 |
| Beta Downside | 0.339 |
| Drawdowns 3y | |
|---|---|
| Max DD | 11.38% |
| CAGR/Max DD | 0.65 |
Description: BCI abrdn Bloomberg All January 14, 2026
The abrdn Bloomberg All Commodity Strategy K-1 Free ETF (NYSE ARCA: BCI) seeks to deliver the total return of a fully collateralized position in the Bloomberg Commodity Index™ (BCOM). BCOM is a diversified, highly liquid benchmark composed of futures on physical commodities across energy, metals, and agriculture. The ETF gains exposure by holding these futures through a Cayman-registered subsidiary, and it is classified as a non-diversified fund under U.S. regulations.
Key market data points: BCI tracks an index covering roughly 23 commodities, with energy futures (crude oil, natural gas) typically accounting for ~55% of the weight, while agriculture and metals fill the remainder. The fund’s expense ratio sits around 0.70%, and historical tracking error has averaged 0.15% ± 0.05% per annum. Performance tends to be positively correlated (≈0.45) with US CPI inflation, making it a potential hedge during periods of rising consumer prices, while its beta to the S&P 500 is near zero, indicating low equity market co-movement.
If you want a deeper, data-driven view of how BCI fits into a multi-asset strategy, a quick look at ValueRay’s commodity analytics can help you spot the next high-expected-value entry point.
What is the price of BCI shares?
Over the past week, the price has changed by -2.95%, over one month by +4.88%, over three months by +11.00% and over the past year by +17.37%.
Is BCI a buy, sell or hold?
What are the forecasts/targets for the BCI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 25.2 | 19.7% |
BCI Fundamental Data Overview February 05, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 2.14b USD (2.14b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 2.14b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 2.14b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 6.89% (E(2.14b)/V(2.14b) * Re(6.89%) + (debt-free company))
Discount Rate = 6.89% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Fair Price DCF = unknown (Cash Flow 0.0)